Advance | $8,550,000 | (Feb 6, 2026)
Turnstile | $29,000,000 | (Feb 6, 2026)
Accrual | $75,000,000 | (Feb 6, 2026)
Certified by Founder
Lodge
CHARM Therapeutics
start up
United Kingdom
- London
- 09/06/2022
- Series A
- $50,000,000
Harnessing the power of deep learning on 3D molecular configurations to deliver medicines of transformational efficacy to patients.
- Industry Research Services
- Website https://charmtx.com/
- LinkedIn https://www.linkedin.com/company/charm-therapeutics/
Related People
Laksh AithaniFounder
United Kingdom -
London, England,
Passionate about drug discovery and machine learning
Connect Music | $80,000,000 | (Feb 6, 2026)
adaption | $50,000,000 | (Feb 6, 2026)
Cadastral | $9,500,000 | (Feb 6, 2026)
Nixtla | $16,000,000 | (Feb 6, 2026)
Nullify | $12,500,000 | (Feb 6, 2026)
Uplift360 | $8,724,008 | (Feb 6, 2026)
Fundamental | $255,000,000 | (Feb 6, 2026)
Duna | $35,365,500 | (Feb 6, 2026)
Flock AI | $6,000,000 | (Feb 6, 2026)